sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Middle East and Africa Ocular Drug Delivery Market...

中东和非洲眼部药物输送市场预测至 2028 年 - COVID-19 影响和区域技术分析（植入式眼部药物输送系统、颗粒药物输送系统、纳米颗粒药物输送系统等）、制剂类型（脂质体和纳米颗粒） 、溶液、乳剂、混悬剂和软膏）、疾病类型（青光眼、糖尿病视网膜病变、干眼综合症、黄斑变性、白内障、糖尿病黄斑水肿等）和最终用户（医院、眼科诊所和门诊手术中心）

TIPRE00025782 | Pages: 135 | Pharmaceuticals | Nov 2021 | Type: Regional | Status: Published

市场介绍

中东及中东地区非洲眼部给药市场包括阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区的综合市场。该地区在其他地区中排名第四，沙特阿拉伯是中东地区最大的市场。非洲地区。沙特阿拉伯在改善眼睛健康方面取得了长足进步。根据世界卫生组织的数据，沙特阿拉伯约有 8,000 名儿童患有功能性低视力。先天性青光眼是该国儿童失明的主要原因之一。此外，在预测期内，计算机和智能手机的使用增加正在创造对眼科药物的需求。预防失明和失聪已被纳入沙特阿拉伯新的初级卫生保健政策。为了保持眼保健的连续性，现有卫生机构正在制定一项为期 5-10 年的计划，其中包括早产儿视网膜病变 (ROP)、学前视力、糖尿病视网膜病变、青光眼和白内障的筛查。卫生部目前正在全国范围内另外建立四个眼科中心来提供这些服务。卫生部已重新启动其防盲 (PB) 部门，并将运营责任转移至负责公共卫生和非传染性疾病 (NCD) 的领域。 2013 年，大约 266 万美元被分配用于专门用于糖尿病视网膜病变筛查、青光眼方案制定、ROP 和学前筛查以及其他研究的失明预防。

COVID-19 大流行已成为该地区最重大的挑战。中东国家的新冠病例数量有所增加。该地区许多国家的卫生系统欠发达且资金不足。除此之外，大量人口已经面临日益沉重的非传染性疾病负担，使他们更容易感染病毒。然而，鉴于“社交距离”的要求，全球许多会议已被取消或推迟。最大的眼科会议之一、原定在南非开普敦举行的世界眼科大会已完全在线上举行，并举行虚拟会议。预计这些因素将在短期内对该地区眼部给药市场的增长产生负面影响。然而，随着疫苗接种的进展以及疫情得到控制，该地区将为眼科药物输送市场的市场参与者提供一些增长前景。

市场概况和动态

中东和非洲的眼部药物输送市场非洲预计将从2021年的12.7246亿美元增长到2028年的8.3088亿美元。预计2021年至2028年该市场将以6.3%的复合年增长率增长。眼部疾病的发病率显着增加。近年来，我们采取了各种措施和努力来提高人们对眼病的认识并进行教育，帮助患者获得适合此类疾病的药物和治疗。 Sightsavers 是一个国际非政府组织，致力于在发展中国家治疗和预防眼部疾病。印度大量人口居住在农村地区，他们对眼病的认识有限或根本没有。通过其农村眼健康计划，Sightsavers 旨在提高农村人口的意识、提供高质量的眼健康服务并消除可避免的失明。因此，不断增长的眼睛健康意识计划可能会为市场创造增长机会。

关键细分市场

中东&非洲眼部给药市场根据技术、制剂类型、疾病类型、最终用户进行细分。按技术划分，2021年植入式眼部给药系统份额最高。按制剂类型划分，2021年解决方案份额最高。按疾病类型划分，2021年白内障细分市场份额最高. 基于最终用户，医院细分市场在 2021 年占据最高份额。

主要来源和上市公司

一些准备本中东和中东地区眼部药物输送市场报告时提到的主要一手和二手资料来源非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有艾伯维公司（AbbVie Inc.）；博士健康公司；诺华公司； Clearside 生物医学公司； Alimera Sciences, Inc. 等等。

购买报告的理由

  • 通过确定中东和非洲地区的增长、规模、领先参与者和细分市场，节省和减少进行入门级研究的时间。非洲眼部药物输送市场
  • 重点介绍关键业务重点，以帮助公司调整业务战略
  • 主要调查结果和建议强调了中东和非洲地区重要的进步行业趋势。非洲眼部药物输送市场，从而使价值链上的参与者能够制定有效的长期战略
  • 通过利用发达和新兴市场的大幅增长产品来制定/修改业务扩张计划
  • 仔细审查深入中东及中东地区非洲市场趋势和前景，以及推动和阻碍眼部药物输送市场的因素
  • 通过了解支持客户产品、细分、定价和分销

中东和中东地区非洲眼部给药市场细分

 

中东及非洲眼部药物输送市场 –按技术划分

  • 植入式眼部药物输送系统
  • 颗粒药物输送系统
  • 纳米粒子给药系统
  • 其他

中东和中东非洲眼部药物输送市场 –按配方类型

  • 溶液
  • 软膏
  • 悬浮液
  • 乳液
  • 脂质体和纳米颗粒
< br />

中东和中东地区非洲眼部药物输送市场 –按疾病类型

  • 白内障
  • 干眼症
  • 黄斑变性
  • 青光眼
  • 糖尿病视网膜病变
  • 糖尿病性黄斑水肿
  • 其他

中东和中东地区非洲眼部药物输送市场 –按最终用户

  • 医院
  • 眼科诊所
  • 门诊手术中心

中东和中东地区非洲眼部药物输送市场 –按国家/地区

  • 沙特阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

中东和中东地区非洲眼部药物输送市场 –提及的公司

  • AbbVie Inc.                               ;        
  • 博士健康公司有限公司          
  • 诺华公司;                  &n公共服务提供商; 
  • Clearside 生物医学公司;       
  • Alimera Sciences, Inc.             

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Middle East & Africa Ocular Drug Delivery Market – By Technology

1.3.2        Middle East & Africa Ocular Drug Delivery Market – By Formulation Type

1.3.3        Middle East & Africa Ocular Drug Delivery Market – By Disease Type

1.3.4        Middle East & Africa Ocular Drug Delivery Market – By End User

1.3.5        Middle East & Africa Ocular Drug Delivery Market – By Country

2.          Middle East & Africa Ocular Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Middle East & Africa Ocular Drug Delivery Market – Market Landscape

4.1        Overview

4.2        Expert Opinions

5.          Middle East & Africa Ocular Drug Delivery Market– Key Market Dynamics

5.1        Market Drivers

5.1.1        Accelerated Research on Ocular Drug Delivery

5.2        Market Restraints

5.2.1        Side Effects Associated with Ocular Drug Delivery

5.3        Market Opportunities

5.3.1        Growing Awareness About Vision Care

5.4        Future Trends

5.4.1        Emergence of Innovative Products

5.5        Impact analysis

6.          Middle East & Africa Ocular Drug Delivery – Market Analysis

6.1        Middle East & Africa Ocular Drug Delivery Market Revenue Forecast and Analysis

7.          Middle East & Africa Ocular Drug Delivery Market Analysis – By Technology

7.1        Overview

7.2        Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3        Implantable Ocular Drug Delivery Systems

7.3.1        Overview

7.3.2        Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4        Particulate Drug Delivery Systems

7.4.1        Overview

7.4.2        Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5        Nano-Particle Drug Delivery System

7.5.1        Overview

7.5.2        Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6        Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

8.          Middle East & Africa Ocular Drug Delivery Market Analysis – By Formulation Type

8.1        Overview

8.1.1        Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2        Liposomes and Nanoparticles Market

8.2.1        Overview

8.2.2        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3        Solution

8.3.1        Overview

8.3.2        Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4        Emulsion

8.4.1        Overview

8.4.2        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5        Suspension

8.5.1        Overview

8.5.2        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6        Ointment

8.6.1        Overview

8.6.2        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9.          Middle East & Africa Ocular Drug Delivery Market Analysis – By Disease Type

9.1        Overview

9.2        Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3        Cataract

9.3.1        Overview

9.3.2        Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4        Dry Eye Syndrome

9.4.1        Overview

9.4.2        Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5        Macular Degeneration

9.5.1        Overview

9.5.2        Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6        Glaucoma

9.6.1        Overview

9.6.2        Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7        Diabetic Retinopathy

9.7.1        Overview

9.7.2        Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8        Diabetic Macular Edema

9.8.1        Overview

9.8.2        Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9        Others

9.9.1        Overview

9.9.2        Others Market Revenue and Forecast to 2028 (US$ Million)

10.       Middle East & Africa Ocular Drug Delivery Market Analysis – By End User

10.1      Overview

10.2      Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Ophthalmic Clinics

10.4.1     Overview

10.4.2     Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5      Ambulatory Surgical Centers

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11.       Middle East & Africa Ocular Drug Delivery Market – Country Analysis

11.1      Middle East & Africa Ocular Drug Delivery Market

11.1.1     Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1       Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2       Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4       Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5       Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2       UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2       UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4       UAE: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5       UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3       South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2       South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4       South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5       South Africa: Ocular Drug Delivery Market, by End user– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6       Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.7       Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.8       Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.9       Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.10    Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)

12.       Impact Of COVID-19 Pandemic on Middle East & Africa Ocular Drug Delivery Market

12.1      Impact Assessment of COVID-19 Pandemic

13.       Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.       Company Profiles

14.1      AbbVie Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bausch Health Companies Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Alimera Sciences, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Novartis AG

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Clearside Biomedical, Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.       Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.            Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.            Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.            Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.            Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.            UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6.            UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.            UAE: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.            UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.            South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Africa: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done by Companies

Table 19.          Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1.           Middle East & Africa Ocular Drug Delivery Market Segmentation

Figure 2.           Middle East & Africa Ocular Drug Delivery Market Segmentation, By Country

Figure 3.           Middle East & Africa Ocular Drug Delivery Market Overview

Figure 4.           Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           Middle East & Africa Ocular Drug Delivery Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9.           Middle East & Africa Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10.        Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11.        Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16.        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22.        Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30.        Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32.        Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33.        Middle East & Africa: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (US$ Million)

Figure 34.        Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35.        Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                       
  5. Alimera Sciences, Inc.                          
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution 
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription